Volume 62, Issue 5 pp. 561-564

Evaluation of the IgE cross-reactions among vespid venoms. A possible approach for the choice of immunotherapy

B. Caruso

B. Caruso

Laboratory of Clinical Chemistry and Haematology, Verona General Hospital, Verona

Search for more papers by this author
P. Bonadonna

P. Bonadonna

Allergy Service, Verona General Hospital, Verona

Search for more papers by this author
M. G. Severino

M. G. Severino

Laboratory and Clinical Allergy Services S. Giovanni di Dio Hospital Firenze, Firenze

Search for more papers by this author
M. Manfredi

M. Manfredi

Laboratory and Clinical Allergy Services S. Giovanni di Dio Hospital Firenze, Firenze

Search for more papers by this author
A. Dama

A. Dama

Allergy Service, Verona General Hospital, Verona

Search for more papers by this author
M. Schiappoli

M. Schiappoli

Allergy Service, Verona General Hospital, Verona

Search for more papers by this author
P. Rizzotti

P. Rizzotti

Laboratory of Clinical Chemistry and Haematology, Verona General Hospital, Verona

Search for more papers by this author
G. Senna

G. Senna

Allergy Service, Verona General Hospital, Verona

Search for more papers by this author
G. Passalacqua

G. Passalacqua

Allergy and Respiratory Diseases, DIMI, University of Genoa, Genoa, Italy

Search for more papers by this author
First published: 12 April 2007
Citations: 56
Giovanni Passalacqua MD
Allergy and Respiratory Diseases
Department of Internal Medicine
Padiglione Maragliano
L.go R. Benzi 10
16132 Genoa
Italy

Abstract

Background: Hymenoptera venom allergy can be effectively cured with specific immunotherapy, thus the correct identification of the allergen is essential. In the case of multiple skin and serum positivities it is important to know if a cross-reaction among venoms is present. We studied by CAP-inhibition assays the degree of cross-reactivity between Vespula vulgaris and Polistes dominulus.

Methods: Serum samples were obtained from consecutive patients with a clinical history of grade III–IV reactions to hymenoptera sting and with nondiscriminative skin/CAP positivity to both Vespula and Polistes. Inhibition assays were carried out with a CAP method, incubating the sera separately with both venoms and subsequently measuring the specific immunoglobulin E (IgE) to venoms themselves.

Results: Forty-five patients (33 male, mean age 40 years, age range 12–74, total serum IgE 242 ± 168 kU/l) were included. Their specific IgE to Vespula and Polistes were 12.03 ± 5.70 kU/l and 10.7 ± 2.0 kU/l (P = NS), respectively. At the CAP-inhibition assays, in 25 patients a >75% heterologous inhibition by P. dominulus venom against V. vulgaris-specific IgE was found. In six subjects V. vulgaris venom effectively inhibited the P. dominulus-specific IgE. In the remaining 14 cases the CAP-inhibition test provided intermediate and not discriminative results.

Conclusion: In 31/45 patients, the double sensitizations to venoms were probably the result of cross-reactions and the CAP-inhibition allowed identifying the true double sensitizations. This approach may be helpful for the correct prescription of immunotherapy in the case of V. vulgaris and P. dominulus double positivity.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.